Filing Details

Accession Number:
0001237648-20-000071
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-30 15:56:22
Reporting Period:
2020-11-27
Accepted Time:
2020-11-30 15:56:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA In Vitro & In Vivo Diagnostic Substances (2835) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1737532 D Jason Aroesty 3760 Rocky Mountain Avenue
Loveland CO 80538
Evp, International Diagnostics No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-27 11,460 $106.67 11,460 No 4 M Direct
Common Stock Acquisiton 2020-11-27 1,874 $106.67 13,334 No 4 M Direct
Common Stock Disposition 2020-11-27 10,233 $126.68 3,101 No 4 S Direct
Common Stock Disposition 2020-11-27 3,101 $127.44 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2020-11-27 1,874 $0.00 1,874 $106.67
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-11-27 11,460 $0.00 11,460 $106.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
937 2018-07-25 2028-07-24 No 4 M Direct
5,729 2018-07-25 2028-07-24 No 4 M Direct
Footnotes
  1. The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.16 to $127.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected
  2. The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.16 to $127.855. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected